Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Diabetic Medicine : a Journal of the British Diabetic Association|December 16, 2024
Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensusSamuel Seidu, Lorraine Avery, Heather Bell, et al.
Plos One|March 28, 2018
Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIVDavid A Garber, James Mitchell, Debra Adams, et al.
Human Molecular Genetics|December 17, 2013
Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathyDebbie Hicks, Golara Torabi Farsani, Steven Laval, et al.
Oncotarget|October 1, 2015
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trialSteven C Clifford, Birgitta Lannering, Ed C Schwalbe, et al.
Mayo Clinic Proceedings|September 6, 2016
New Insulin Delivery RecommendationsAnders H Frid, Gillian Kreugel, Giorgio Grassi, et al.
Journal of Neurosurgery. Pediatrics|January 18, 2020
Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 studyElizabeth Schepke, Magnus Tisell, Colin Kennedy, et al.
Orphanet Journal of Rare Diseases|September 8, 2017
Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular DystrophyElizabeth Harris, Ana Topf, Rita Barresi, et al.
Journal of Medical Primatology|January 15, 2013
Evaluation of the lymphocyte trafficking drug FTY720 in vaginal tissuesAi Tsuiki, Wei Luo, Tara Henning, et al.
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2026
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes ManagementPhilip Newland-Jones, Partha Kar, Beth Kelly, et al.
Pageof 8